Literature DB >> 17597998

Antithrombin--early prophecies and present challenges.

Ulrich Abildgaard1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17597998

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  10 in total

1.  Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.

Authors:  Bryce A Kerlin; Amanda P Waller; Ruchika Sharma; Melinda A Chanley; Marvin T Nieman; William E Smoyer
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

2.  The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency.

Authors:  Irene Martínez-Martínez; José Navarro-Fernández; Sonia Aguila; Antonia Miñano; Nataliya Bohdan; María Eugenia De La Morena-Barrio; Adriana Ordóñez; Constantino Martínez; Vicente Vicente; Javier Corral
Journal:  Mol Med       Date:  2012-07-18       Impact factor: 6.354

3.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

4.  Cloning of the full-length cDNA of porcine antithrombin III and comparison with its human homolog.

Authors:  Younan Chen; Weidong Tan; Shengfang Qin; Jie Zhang; Hong Bu; Youping Li; Yanrong Lu; Jingqiu Cheng
Journal:  Comp Med       Date:  2009-08       Impact factor: 0.982

5.  Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation.

Authors:  Mariya Negreva; Svetoslav Georgiev; Krasimira Prodanova; Julia Nikolova
Journal:  Cardiol Res       Date:  2016-06-24

6.  Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.

Authors:  David Pereyra; Florian Offensperger; Florian Klinglmueller; Stefanie Haegele; Lukas Oehlberger; Thomas Gruenberger; Christine Brostjan; Patrick Starlinger
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

7.  A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress.

Authors:  Jingjing Su; Liang Shu; Zhou Zhang; Lei Cai; Xin Zhang; Yu Zhai; Jianren Liu
Journal:  Oncotarget       Date:  2016-11-22

8.  Deciphering the role of trehalose in hindering antithrombin polymerization.

Authors:  Asma Naseem; Mohammad Sazzad Khan; Hashim Ali; Irshad Ahmad; Mohamad Aman Jairajpuri
Journal:  Biosci Rep       Date:  2019-04-05       Impact factor: 3.840

9.  Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.

Authors:  Jennie Bäck; Christian Lood; Anders A Bengtsson; Kristina Nilsson Ekdahl; Bo Nilsson
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

10.  Analysis of protein missense alterations by combining sequence- and structure-based methods.

Authors:  Aram Gyulkhandanyan; Alireza R Rezaie; Lubka Roumenina; Nathalie Lagarde; Veronique Fremeaux-Bacchi; Maria A Miteva; Bruno O Villoutreix
Journal:  Mol Genet Genomic Med       Date:  2020-02-25       Impact factor: 2.183
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.